Kiel Kim

Kiel Kim has served as a member of their board of directors since June 2021. Mr. Kim is currently a Vice President on Bio Investment Center at SK Inc. and has been in charge of investing in SK Inc.’s biopharmaceutical portfolio companies. Mr. Kim joined SK Inc. in January 2021 and focuses on investments in both preclinical-stage and early clinical-stage pharmaceutical companies. Prior to joining SK Inc., Mr. Kim was a co-founder and Chief Executive Officer of NS Investment for over five years, where he led investments in preclinical-stage and early clinical-stage biotechnology companies based in the United States and Germany. He received his MBA from Korea University and is a Certified Public Accountant in the state of Delaware.